pharmaphorum February 6, 2024
Nicole Raleigh

EU Clinical Trials Regulation (EU CTR) has been a hot topic for a little while now. An initiative launched by the European Commission, EMA, and national regulators within the EU in 2022 in order to change the way clinical trials are designed and run, so as to position Europe as an area of clinical trial excellence internationally, via a harmonised strategy between member states – the deadline for sponsors to transition ongoing trials to EU CTR comes into effect in January 2025.

So it was that for the latest episode of the pharmaphorum podcast web editor Nicole Raleigh sat down with Chris Bamford, director of clinical trial regulatory management at IQVIA, and Shirley Rutter, associate director and strategic quality lead...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Conferences / Podcast, Govt Agencies, Regulations, Trends
Pregnant People Can Freely Make Decisions About Participation In Clinical Research
InnovationRx: Positive Clinical Trial Results For Generative AI-Designed Drug
Copayment Burden Affects Medication Adherence in Chronic Conditions
Neurogene hits a setback in the clinic, days after fundraise
How to adapt to choppy waters in biotech ecosystem

Share This Article